KA06 Fetus or newborn affected by noxious influences transmitted via placenta or breast milk

International Classification of Diseases for Mortality and Morbidity Statistics, 11th Revision, v2025-01

A group of conditions characterised by findings in the fetus or newborn due to the transmission of any harmful or poisonous substance to the fetus or newborn via the placenta or in breast milk.

inclusions

• nonteratogenic effects of substances transmitted via placenta

exclusions

• congenital malformations  (Chapter 20)
• Neonatal hyperbilirubinaemia due to drugs or toxins transmitted from mother  (KA87.4)

sections/codes in this section ()

• Fetus or newborn affected by maternal anaesthesia or analgesia in pregnancy, labour or delivery  (KA06.0)
• Fetus or newborn affected by maternal use of tobacco  (KA06.1)
• Fetus or newborn affected by maternal use of alcohol  (KA06.2)
• Fetus or newborn affected by maternal use of drugs of addiction  (KA06.3)
• Fetus or newborn affected by maternal use of nutritional chemical substances  (KA06.4)
• Fetus or newborn affected by maternal exposure to environmental chemical substances  (KA06.5)
• Fetus or newborn affected by other specified noxious influence transmitted via placenta or breast milk  (KA06.Y)
• Fetus or newborn affected by unspecified noxious influence transmitted via placenta or breast milk  (KA06.Z)

coding note

These codes are for use when the listed maternal conditions are specified as the cause of confirmed morbidity or potential morbidity which have their origin in the perinatal period (before birth through the first 28 days after birth). Use additional code to identify the condition in the fetus or newborn.

postcoordination

Thank you for choosing Find-A-Code, please Sign In to remove ads.